DS
SGNT

David Shaw’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

David Shaw’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-39,368
Closed -$590K – 3709
2016
Q2 		$590K Sell
39,368
-43,703
-53% -$561K ﹤0.01% 2715
2016
Q1 		$1.01M Buy
83,071
+51,917
+167% +$728K ﹤0.01% 2344
2015
Q4 		$496K Buy
+31,154
New +$490K ﹤0.01% 3100
2014
Q1 		– Sell
-11,713
Closed -$297K – 4866
2013
Q4 		$297K Sell
11,713
-83,956
-88% -$1.9M ﹤0.01% 4065
2013
Q3 		$1.95M Buy
+95,669
New +$2.13M ﹤0.01% 2450

David Shaw's SGNT Position: Q3 2016 in Review

David Shaw sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 39,368 shares — an estimated $590K sold.

David Shaw first reported a position in SGNT in Q3 2013 and held it in 5 quarters. The position peaked at $1.95M in Q3 2013. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • David Shaw reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • David Shaw sold 39,368 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $590K.
  • David Shaw first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q3 2013 and held it in 5 quarters.
  • David Shaw's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $1.95M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on D.E. Shaw & Co's 13F filing for Q3 2016, filed 14 Nov 2016.